71 related articles for article (PubMed ID: 9877241)
1. Microphysiometry: new technology for evaluation of anticancer drug activity in human tumor cells in vitro.
Ekelund S; Nygren P; Larsson R
Anticancer Drugs; 1998 Jul; 9(6):531-8. PubMed ID: 9877241
[TBL] [Abstract][Full Text] [Related]
2. The effect of functional groups on reduction and activation of quinone bioreductive agents by DT-diaphorase.
Fourie J; Oleschuk CJ; Guziec F; Guziec L; Fiterman DJ; Monterrosa C; Begleiter A
Cancer Chemother Pharmacol; 2002 Feb; 49(2):101-10. PubMed ID: 11862423
[TBL] [Abstract][Full Text] [Related]
3. Impedance studies of bio-behavior and chemosensitivity of cancer cells by micro-electrode arrays.
Liu Q; Yu J; Xiao L; Tang JC; Zhang Y; Wang P; Yang M
Biosens Bioelectron; 2009 Jan; 24(5):1305-10. PubMed ID: 18783935
[TBL] [Abstract][Full Text] [Related]
4. A cell-microelectronic sensing technique for profiling cytotoxicity of chemicals.
Boyd JM; Huang L; Xie L; Moe B; Gabos S; Li XF
Anal Chim Acta; 2008 May; 615(1):80-7. PubMed ID: 18440366
[TBL] [Abstract][Full Text] [Related]
5. Targeted cancer therapy: conferring specificity to cytotoxic drugs.
Chari RV
Acc Chem Res; 2008 Jan; 41(1):98-107. PubMed ID: 17705444
[TBL] [Abstract][Full Text] [Related]
6. Multi-channel 3-D cell culture device integrated on a silicon chip for anticancer drug sensitivity test.
Torisawa YS; Shiku H; Yasukawa T; Nishizawa M; Matsue T
Biomaterials; 2005 May; 26(14):2165-72. PubMed ID: 15576192
[TBL] [Abstract][Full Text] [Related]
7. Analysis of drug action on tumor cell metabolism using electronic sensor chips.
Otto AM; Brischwein M; Motrescu E; Wolf B
Arch Pharm (Weinheim); 2004 Dec; 337(12):682-6. PubMed ID: 15597401
[TBL] [Abstract][Full Text] [Related]
8. The CD95/CD95 ligand system is not the major effector in anticancer drug-mediated apoptosis.
Tolomeo M; Dusonchet L; Meli M; Grimaudo S; D'Alessandro N; Papoff G; Ruberti G; Rausa L
Cell Death Differ; 1998 Sep; 5(9):735-42. PubMed ID: 10200532
[TBL] [Abstract][Full Text] [Related]
9. Noninvasive real-time monitoring of intracellular cancer cell metabolism and response to lonidamine treatment using diffusion weighted proton magnetic resonance spectroscopy.
Mardor Y; Kaplan O; Sterin M; Ruiz-Cabello J; Ash E; Roth Y; Ringel I; Cohen JS
Cancer Res; 2000 Sep; 60(18):5179-86. PubMed ID: 11016646
[TBL] [Abstract][Full Text] [Related]
10. A model-based approach to the in vitro evaluation of anticancer activity.
Del Bene F; Germani M; De Nicolao G; Magni P; Re CE; Ballinari D; Rocchetti M
Cancer Chemother Pharmacol; 2009 Apr; 63(5):827-36. PubMed ID: 18663447
[TBL] [Abstract][Full Text] [Related]
11. Application of silicon sensor technologies to tumor tissue in vitro: detection of metabolic correlates of chemosensitivity.
Mestres-Ventura P; Morguet A; Schofer A; Laue M; Schmidt W
Methods Mol Med; 2005; 111():109-25. PubMed ID: 15911976
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and biological evaluation of new symmetrical derivatives as cytotoxic agents and apoptosis inducers.
Sanmartín C; Echeverría M; Mendívil B; Cordeu L; Cubedo E; García-Foncillas J; Font M; Palop JA
Bioorg Med Chem; 2005 Mar; 13(6):2031-44. PubMed ID: 15727857
[TBL] [Abstract][Full Text] [Related]
13. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
[TBL] [Abstract][Full Text] [Related]
14. Cell-based chip for the detection of anticancer effect on HeLa cells using cyclic voltammetry.
El-Said WA; Yea CH; Kim H; Oh BK; Choi JW
Biosens Bioelectron; 2009 Jan; 24(5):1259-65. PubMed ID: 18782663
[TBL] [Abstract][Full Text] [Related]
15. Levels of phospholipid metabolites in breast cancer cells treated with antimitotic drugs: a 31P-magnetic resonance spectroscopy study.
Sterin M; Cohen JS; Mardor Y; Berman E; Ringel I
Cancer Res; 2001 Oct; 61(20):7536-43. PubMed ID: 11606391
[TBL] [Abstract][Full Text] [Related]
16. In vitro characterization of the anticancer activity of membrane-active cationic peptides. I. Peptide-mediated cytotoxicity and peptide-enhanced cytotoxic activity of doxorubicin against wild-type and p-glycoprotein over-expressing tumor cell lines.
Johnstone SA; Gelmon K; Mayer LD; Hancock RE; Bally MB
Anticancer Drug Des; 2000 Apr; 15(2):151-60. PubMed ID: 10901303
[TBL] [Abstract][Full Text] [Related]
17. High concordance of drug-induced human hepatotoxicity with in vitro cytotoxicity measured in a novel cell-based model using high content screening.
O'Brien PJ; Irwin W; Diaz D; Howard-Cofield E; Krejsa CM; Slaughter MR; Gao B; Kaludercic N; Angeline A; Bernardi P; Brain P; Hougham C
Arch Toxicol; 2006 Sep; 80(9):580-604. PubMed ID: 16598496
[TBL] [Abstract][Full Text] [Related]
18. Potentiation of anti-cancer drug activity at low intratumoral pH induced by the mitochondrial inhibitor m-iodobenzylguanidine (MIBG) and its analogue benzylguanidine (BG).
Kuin A; Aalders M; Lamfers M; van Zuidam DJ; Essers M; Beijnen JH; Smets LA
Br J Cancer; 1999 Feb; 79(5-6):793-801. PubMed ID: 10070871
[TBL] [Abstract][Full Text] [Related]
19. In vitro test-system for chemo- and thermosensitivity: an analysis of survival fractions and cell-cycle distributions in human Ewing's sarcomas as a modelfor tumors in pediatric oncology.
Debes A; Rommel F; Breise M; Willers R; Göbel U; Wessalowski R
Klin Padiatr; 2002; 214(4):223-9. PubMed ID: 12165906
[TBL] [Abstract][Full Text] [Related]
20. Anticancer Drug Development: The Way Forward.
Connors T
Oncologist; 1996; 1(3):180-181. PubMed ID: 10387985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]